The Karnataka Health Department has issued an advisory in response to the detection of the Zika virus in a mosquito species in Chikkaballap...

Research suggests it is more than 75% effective and that protection is maintained for at least another year with a booster. Tedros said the...

Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top execu...

On Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...

Under the alliance, BBL will get committed access to 100 million doses of vaccines annually for 15 years and commercialisation rights of th...

Health Secretary J Radhakrishnan, who inspected the administering of the second dose to healthcare workers at the Government Rajiv Gandhi G...

Many patient samples had also yielded false positive in dengue diagnosis tests.

Pune-based Serum Institute, credited with affordable and innovative therapies like pneumonia and dengue monoclonal vaccines, plans to price...

There are a couple of diseases which are on the radar of the health ministry and malaria is one of them, the Union Health Minister said.

Scientific details of the vaccines remained unclear. However, the vaccine maker said it will begin registrations for the vaccine soon.

The company sells its products in 147 countries and is the largest vaccines manufacturer by dosage globally with 1.2 billion doses per annu...

The company is also developing vaccine and drug for dengue fever. It has commenced first phase of trials in Singapore and hopes to launch v...

Serum Institute will develop a drug to treat all 4 strains of dengue, and is in the process of applying for a 'speedy approval' to roll-out...

The new MIT device relies on lateral flow technology, which is used in pregnancy tests and has recently been exploited for diagnosing strep...

The device developed by The Institute of Bioengineering and Nanotechnology (IBN) in Singapore is currently undergoing further development.

The company will be making vaccines for pneumonia, rotavirus, dengue and many other diseases in the plant, Adar C Poonawalla dded.

The challenge is to build on India's recent successes in vaccine research to reach the global cutting edge in producing vaccines for killer...